Altris AI, which offers OCT analysis for retinal diseases, is now expanding to glaucoma detection.With its optic disc ...

A study demonstrates how heart ... Food Insecurity Today, Heart Disease Tomorrow? Mar. 12, 2025 — Struggling to afford food today could mean heart problems tomorrow. Young adults experiencing ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...

Patients suffering from debilitating spine problems now have a leading expert to turn to-Dr. Michael R. Wheeler, MD, a distinguished spi ...

Aurora Spine completed enrollment for its Refine study on lumbar interlaminar fusion, according to a March 10 news release.

Spinal Stabilization Technologies enrolled its first U.S. patient in the Investigational Device Exemption clinical trial for its PerQdisc Nucleus Replacement Device.

PETACH-TIKVA, Israel, March 04, 2025 (GLOBE NEWSWIRE) -- Discure Technologies, a clinical-stage medical device company ...

The Food and Drug Administration (FDA) has granted Fast Track designation to BRTX-100 for the treatment of chronic lumbar disc disease, defined as back and/or radicular pain with confirmed ...

Extracellular vesicles (EVs) have constituted a prominent area of research in recent years. As a mediator of intercellular communication, EVs play an ...

BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting –– IND ...

Lower back pain affects millions of people every year. About 80% of people will experience back pain at some point in their ...